Position in IDXX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,423
-$567 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,187
of 1,286 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Solstein Capital, LLC holds $1,199,891 across 6 Diagnostics & Research names. IDXX ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,964 | $984,671 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
600 | $136,074 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
67 | $35,482 | |
| 4 | DHR |
Danaher Corp /De/
|
175 | $33,334 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
This page
|
16 | $8,423 | |
| 6 | DGX |
Quest Diagnostics Inc
|
9 | $1,907 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,423 | 16 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,990 | 16 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,824 | 16 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,222 | 16 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,581 | 16 | Shares | Sole | 2025-08-01 | |
| 2020-03-31 | $1,695 | 7 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||